Minimal change disease screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Minimal change disease}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to..." |
|||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for | There is insufficient evidence to recommend routine screening for minimal change disease.However, according to International Study of Kidney Disease genetic screening for minimal change disease is recommended when the patient is not responsive to steroids within 4 weeks of the treatment started. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for | * There is insufficient evidence to recommend routine screening for minimal change disease. | ||
* However,according to International Study of Kidney Disease genetic screening for minimal change disease is recommended along with performing a renal biopsy when the patient is not responsive to steroids within 4 weeks of the treatment started. | |||
==References== | ==References== | ||
Revision as of 20:50, 10 May 2018
|
Minimal Change Disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Minimal change disease screening On the Web |
|
American Roentgen Ray Society Images of Minimal change disease screening |
|
Risk calculators and risk factors for Minimal change disease screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for minimal change disease.However, according to International Study of Kidney Disease genetic screening for minimal change disease is recommended when the patient is not responsive to steroids within 4 weeks of the treatment started.
Screening
- There is insufficient evidence to recommend routine screening for minimal change disease.
- However,according to International Study of Kidney Disease genetic screening for minimal change disease is recommended along with performing a renal biopsy when the patient is not responsive to steroids within 4 weeks of the treatment started.